Company: PTHS
Filing Date: 2025-12-17
Form Type: 8-K
Source: 0001753926-25-001906
Chunk: 1

Company: Pelthos Therapeutics Inc.
Filing Date: 2025-12-17
Form: 8-K
Item: Item 5.07
Chunk 1
---
1  

There were 0 broker non-votes with respect to the third proposal.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this
report to be signed on its behalf by the undersigned hereunto duly authorized.

  Date: December 17, 2025      Pelthos Therapeutics Inc.                                                            
 ────────────────────────────────────────────────────────────────────────────────────────────────────────────────────
                               By:                            /s/ Francis Knuettel II                               
                                                              Name:                        Francis Knuettel II      
                                                              Title:                       Chief Financial Officer